__PreDR__: Drug repositioning from chemical, genomic and pharmacological data in an integrated framework
* Version 0.0.1
* Last updated: Oct. 31, 2013


* Yong-Cui Wang, Nai-Yang Deng, and Yong Wang. (2013) [Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0078518 ]. PLoS ONE 8(12) 


Computational inference of new diseases for existing
drugs (drug repositioning) offers the possibility of faster drug
development and can also reduces risks in drug discovery. Previous
research indicated that drugs with similar chemical structures, target
proteins, or side-effects may always treat similar diseases. However,
each single data source is important in each own way and data
integration is crucial to reposition drug more accurately.


Here, we propose a novel method, named PreDR (Predict
Drug Repositioning), to integrate chemical structures, target proteins,
and side-effects to infer new diseases for existing drugs by uncovering
the potential associations between drugs and diseases. Specially, we
first characterize drug and disease by their similarity-based profiles,
and define the kernel function to correlate drug with disease. Finally,
we train a machine learning model, support vector machine (SVM),
to automatically predict novel drug-disease interactions. PreDR is
validated on a well-established drug-disease networks with 1,933
interactions between 593 drugs and 313 disease. By cross-validation,
we find that all chemical structures, drug targets, and side-effects
information are predictive for drug-disease interactions prediction.
Moreover, by integrating these three properties, more experimentally
observed drug-disease interactions can be revealed. In addition,
database research and disease gene pathway analysis indicate that
our new predictions are worthy of future experimental validation. We
further test our novel prediction under clinical trials, and show the
significant prospect of our new method in future drug treatment.

This version of the program is in very preliminary stage and provided just for testing purpose. The program is still under development.

* [PreDR.zip|software.zip]


* [Data.zip|dataset.zip]

Category: [Supplementary] [Software]